ing task. Conclusions: MRI measures suggestive of Alzheimer-type pathology and microvascular pathology independently contribute to cognitive decline at old age. Memory impairment as measured using the Wechsler Memory Scale and performance on Trails B primarily depended on medial temporal lobe atrophy. Psychomotor slowness, as measured using Trails A, mainly depended on WMH. These results suggest that vascular pathology and Alzheimer-type pathology each have specifi c cognitive correlates.
In analogy, the neuropathological changes presumed to underly the cognitive decline in AD and MCI also develop gradually. From neuropathological studies, it is known that Alzheimer-type (i.e., neurofi brillary tangles and senile plaques) and vascular pathological changes are the most important correlates of cognitive impairment, with no clear thresholds predicting dementia status [4, 5] . Both types of abnormalities are frequently observed in subjects with dementia as well as in cognitively normal elderly, confi rming the notion of a continuum of both cumulative neuropathology and cognitive decline [4] . The clinical syndrome of dementia may occur when the combined burden of pathology reaches a certain threshold [6] .
On MRI, medial temporal lobe atrophy presumably refl ects Alzheimer-type pathology, whereas white matter hyperintensities (WMH) are of vascular origin [7, 8] . Medial temporal lobe atrophy and WMH have been shown to coexist in AD [9, 10] . There have been a number of studies addressing the associations between single MRI measures and impairment in cognitive domains. Medial temporal lobe atrophy has been shown to be associated with cognitive decline in AD and MCI [11] [12] [13] [14] [15] . The medial temporal lobes are crucial in memory, which is usually the fi rst cognitive function to deteriorate in AD [16] . WMH have been reported to be associated with poor performance on tasks involving speed in healthy elderly [17, 18] . WMH are more common in patients with AD than in healthy elderly, and associations with dementia severity have been found, although not consistently [19] [20] [21] [22] . When evaluated in mono-factorial studies, both medial temporal lobe atrophy and WMH seem to be associated with cognitive decline. However, as yet it has not been clarifi ed if these measures jointly contribute to the severity of cognitive impairment.
In the present multi-factorial MRI study, we investigated simultaneous associations between quantitative measures of medial temporal lobe atrophy and WMH and neuropsychological measures of global cognition, memory, language ability and psychomotor speed in a sample of subjects representing the cognitive continuum of normal cognition, MCI and AD.
Materials and Methods

Patients
Elderly referred to the outpatient memory clinic of the Leiden University Medical Center participated in this study. All were evaluated for memory complaints using a standardized dementia screening that included a detailed medical history, a general internal and neurologic exam, laboratory tests, neuropsychological testing and MRI. Diagnoses were made in a multidisciplinary consensus meeting. Forty-one patients received a diagnosis of mild to moderate probable AD [1] . MCI was observed in 20 patients [2, 23] . In addition, 28 elderly controls without memory complaints were recruited through an advertisement in a local newspaper. Controls were evaluated in the same way as patients. Patients and controls were excluded if they had neurologic or psychiatric comorbidity, and if they had abnormalities on MRI other than WMH or an incidental small lacunar lesion ( ^ 5 mm in diameter). The study was approved by the local Medical Ethical Committee. Written informed consent was obtained from all subjects or from a close relative if a patient was demented.
Neuropsychological Assessment
Cognitive functions were assessed using a standardized neuropsychological test battery. From this test battery, we selected four neuropsychological tests that refl ect the most important cognitive domains. All are quantitative in nature and widely used in studies assessing dementia. The Cambridge Cognitive Examination (CAM-COG) was used to assess global cognitive functioning [24, 25] . Memory function was evaluated using the Wechsler Memory Scale (WMS) [26] . The Boston naming task was employed to yield a measure of language ability [27] . Psychomotor speed was measured using the Trail Making Test, which consists of a simple (Trails A) and a complex (Trails B) condition [28] .
MRI Data
MRI was performed on a 1.5-tesla MR system (Philips Medical Systems, Best, The Netherlands). T 1 -weighted 3D gradient echo (120 coronal slices; slice thickness = 3 mm; overlap = 1.5 mm; TR/ TE 30/4.6 ms; fl ip angle = 30°; fi eld of view = 220 mm; matrix 256 ! 256), dual fast spin-echo (48 axial slices; slice thickness = 3 mm; no gap; TR/TE 3,000/27/120 ms; fl ip angle = 90°; fi eld of view = 220 mm; matrix 256 ! 256) and fast fl uid attenuated inversion recovery (FLAIR) sequences were obtained in all patients. The line through the inferior border of the genu and splenium of the corpus callosum defi ned the direction of scanning for the dual echo and FLAIR images. The direction of scanning for the T 1 -weighted sequence was perpendicular to this line.
In the diagnostic work-up, MRI was used to rule out other causes of cognitive impairment. For research purposes only, the following quantitative MRI measures were obtained. The T 1 -weighted images were used to obtain intracranial, whole brain and medial temporal lobe volume, whereas the dual echo sequences were used to obtain WMH volume. All measurements were performed by a single rater who was blind to subject identity and diagnosis.
Manual segmentation of the medial temporal lobe (including hippocampus and parahippocampal gyrus) was performed using the interactive software package DISPLAY (Brain Imaging Center of the Montreal Neurological Institute) [29] . Boundaries were adapted from Watson et al. [30, 31] . Briefl y, segmentation of the hippocampus started when the mammillary bodies became visible and ended when the fornix formed a continuous tract. The parahippocampal gyrus started three slices anterior to the hippocampus. The posterior commissure marked its posterior border. Left and right hippocampus and parahippocampal gyrus were summed to obtain the total medial temporal lobe volume.
Semi-automated segmentation of intracranial and whole brain volume and quantifi cation of WMH volume was performed using van der Flier et al. . Segmentations of WMH were generated automatically. Subsequently, the automatically detected lesions were edited manually to correct for incidental inclusion of cerebrospinal fl uid, gray matter and Virchow-Robin spaces. WMH were defi ned as hyperintense lesions on both proton density and T 2 -weighted images. FLAIR hard copies were used as a reference to minimize misclassifi cation. Infratentorial lesions were excluded. To assess the reliability of the automated lesion detection of the software, 9 patients underwent scan-rescan with and without repositioning procedures. Intraclass correlation coeffi cients (ICC) were 1 0.75. In addition, ten randomly selected brains were segmented twice to assess intrarater reliabilities of the medial temporal lobe and WMH volume (ICC for medial temporal lobe volume = 0.91 and for WMH 1 0.99) and interrater reliability of intracranial and whole brain volume (ICC intracranial volume = 0.97, whole brain volume = 1.0).
Statistical Analysis
SPSS for Windows (release 10.0; SPSS, Chicago, Ill., USA) was used for data analysis. Group differences were analyzed using analysis of variance (ANOVA) with post-hoc Bonferroni tests, 2 tests and Kruskal-Wallis tests when appropriate. Univariate associations were assessed using Pearson's correlation analysis. Multiple linear regression analyses were performed to examine independent associations between MRI measures and cognitive impairment. Neuropsychological test results were used as dependent variables. Medial temporal lobe volume and WMH were the predictors. In addition, age, sex and whole brain volume were entered as covariates. The level of statistical signifi cance was set at p ! 0.05.
Results
The sociodemographic characteristics, neuropsychological test results and brain measures of the subjects are presented in table 1 . Diagnostic groups did not differ with respect to sex, age or education. There were signifi cant differences between groups for all neuropsychological tests. Patients with AD scored signifi cantly lower than patients with MCI and controls on all neuropsychological tests (AD ! controls: all p ! 0.001; AD ! MCI: p ! 0.007). Patients with MCI had intermediate scores between AD patients and controls. MCI patients had signifi cantly lower scores than controls on all tests (p ! 0.005) with the exception of Trails A (p = 0.68). Medial temporal lobe volumes were signifi cantly different between groups. Patients with AD and MCI had signifi cantly smaller medial temporal lobes than controls (MCI ! controls: p = 0.015; AD ! controls: p ! 0.001). There were no signifi cant differences between groups in intracranial volume, whole brain volume or WMH.
Across groups, all neuropsychological tests were signifi cantly correlated, and there was a signifi cant correlation between medial temporal lobe volume and WMH ( table 2 ). In the univariate analysis, all neuropsychological tests were correlated with medial temporal lobe volume and WMH, except for the WMS, which was not correlated with WMH ( fi g. 1 ).
Multiple linear regression analyses were performed to investigate the independent contribution of medial temporal lobe volume and WMH to impairment in several 
Discussion
The main fi nding of the present study is that medial temporal lobe atrophy and WMH independently and specifi cally affect cognitive decline at old age. Memory function, as measured using the WMS, and performance on Trails B was preferably associated with medial temporal lobe volume, and psychomotor slowness as measured using Trails A with WMH. Both MRI measures contributed to the CAMCOG and Boston naming task, measures of global cognitive impairment and language disability, respectively.
We recently demonstrated that the combination of medial temporal lobe atrophy and WMH is associated with the presence of dementia [9] . In the present study, we extend these fi ndings, as both MRI measures were shown to independently contribute to the severity of dementia as measured using neuropsychological tests. In contrast with our former study, our current results do not suggest an interaction between medial temporal lobe atrophy and WMH. However, we do not think the two studies are contradictory as they both clearly indicate that WMH and medial temporal lobe atrophy are important contributors to the presence and severity of dementia.
There have been a number of studies addressing the associations between single MRI measures and impairment in cognitive domains. Medial temporal lobe atrophy has repeatedly been shown to be associated with cognitive decline, especially memory impairment [13] [14] [15] . However, there is inconsistency in the literature concerning the cognitive correlates of WMH [18] [19] [20] [21] . Psychomotor speed has been mentioned in this respect, but other studies did not fi nd signifi cant associations between WMH and cognitive impairment [17] . In contrast with the above-mentioned mono-factorial studies, the number of studies simultaneously investigating medial temporal lobe atrophy and WMH in relation to impairment in specifi c cognitive functions is limited [32] .
There has been one earlier report examining the cognitive correlates of both hippocampal atrophy and WMH in a sample of subjects covering a broad range of cognitive functioning [32] . In that study, hippocampal volume was a strong independent predictor of several cognitive functions, whereas WMH were weakly associated only with fl uency. In contrast with these fi ndings, we observed independent associations of both medial temporal lobe atrophy and WMH with multiple cognitive functions. Although we consistently observed associations between WMH and cognitive functioning, the associations were of moderate strength. The contrasting results may be explained by our highly reliable method of WMH quantification, that enabled us to reveal these subtle associations. Furthermore, the differences in study sample may be responsible for the contrasting fi ndings. In both studies, subjects with a broad variability of cognitive impairment were included. However, the group of nondemented subjects was overrepresented (81%) in the earlier study, whereas almost half of the participants in the present study consisted of demented patients. It may be speculated that hippocampal atrophy is a prerequisite to develop the fi rst signs of cognitive decline. Once there is MCI, the presence of WMH increases the burden of pathology, thus further worsening cognitive function. This notion is concordant with the brain reserve theory, according to which brain injury may add up until a certain threshold is reached and clinical dementia occurs [6, 33] . It also agrees with the study by Wu et al. [34] , who report that WMH are strongly associated with the presence of dementia.
Strengths of the present study include the broad range of cognitive functioning that was covered, enabling us to appreciate the full spectrum of structural-functional relationships. Quantitative measures of medial temporal lobe atrophy and WMH were used, to assess their independent contributions to cognitive impairment in a sensitive and reliable way. The neuropsychological tests used for this study are widely used to assess cognitive functions in memory clinics. Although each test was chosen to measure functioning in a specifi c cognitive domain, there is in fact substantial overlap between cognitive domains. Therefore, reduced performance on a specifi c test may be caused by impairment in several cognitive domains. For example, Trails B is essentially a test of complex psychomotor speed and executive functioning. However, due to the complex test instructions, it also places a considerable demand on the memory. Moreover, we interpreted the association between medial temporal lobe volume and Trails B as being dependent on memory function, as in our study sample, Trails B seemed to be more strongly associated with the memory test than with the test for simple psychomotor speed. Among the limitations are the small patient numbers, and results need to be replicated in larger samples. Furthermore, we assessed the effect of total WMH on cognitive functions. It is conceivable that regional measures of WMH, like periventricular and subcortical WMH, would have been more specifi c for specifi c aspects of cognition.
In conclusion, we demonstrated that MRI measures suggestive of Alzheimer-type and microvascular pathology independently affect cognitive impairment at old age. Neuropsychological measures of global cognitive function and language ability were associated with both medial temporal lobe atrophy and WMH. Memory impairment was preferentially associated with medial temporal lobe atrophy, whereas performance on a test of psychomotor slowness mainly depended on WMH. These results support the view that Alzheimer-type and microvascular brain pathology signifi cantly contribute to cognitive decline at old age. Moreover, these data provide evidence that vascular pathology and Alzheimer-type pathology each have specifi c cognitive correlates in the elderly.
